Erin Kobetz1,2,3, Julia Seay4,5, Tulay Koru-Sengul5,6, Jordan Baeker Bispo6, Dinah Trevil5, Martha Gonzalez5, Andrew Brickman7, Olveen Carrasquillo4,5. 1. Department of Medicine, University of Miami Miller School of Medicine, Miami-Dade, FL, USA. EKobetz@med.miami.edu. 2. Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami-Dade, FL, USA. EKobetz@med.miami.edu. 3. University of Miami Miller School of Medicine, Clinical Research Building Room 610B, 1120 NW 14th Street, Miami, FL, 33136, USA. EKobetz@med.miami.edu. 4. Department of Medicine, University of Miami Miller School of Medicine, Miami-Dade, FL, USA. 5. Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami-Dade, FL, USA. 6. Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami-Dade, FL, USA. 7. The Health Choice Network, Miami-Dade, FL, USA.
Abstract
PURPOSE: HPV self-sampling has previously been shown to increase cervical cancer screening among ethnic minority and immigrant women. We conducted a randomized pragmatic trial to examine the effectiveness of HPV self-sampling delivered via in-person versus by US mail for medically underserved Hispanic, Haitian, and non-Hispanic Black women living in South Florida. METHODS: We randomized women aged 30-65 who had not completed Pap smear screening in the past 3 years into two groups: (1) HPV self-sampling delivered in-person (IP) by a community health worker (CHW; IP + SS) or (2) HPV self-sampling delivered via US mail (SS + Mail). Our primary outcome was HPV self-sampling completion by 6-month post-study enrollment. RESULTS: We enrolled 600 women. Approximately 65% were Hispanic and 35% were Haitian or non-Hispanic Black. Nearly half (43%) had an income of less than $20,000/year and 67% were uninsured. In intent-to-treat analyses, 71.6% of participants in the SS + Mail group and 81.0% of participants in the IP + SS group completed HPV self-sampling. CONCLUSION:Mailed HPV self-sampling is an effective strategy to increase cervical cancer screening among underserved immigrant and ethnic minority women.
RCT Entities:
PURPOSE:HPV self-sampling has previously been shown to increase cervical cancer screening among ethnic minority and immigrant women. We conducted a randomized pragmatic trial to examine the effectiveness of HPV self-sampling delivered via in-person versus by US mail for medically underserved Hispanic, Haitian, and non-Hispanic Black women living in South Florida. METHODS: We randomized women aged 30-65 who had not completed Pap smear screening in the past 3 years into two groups: (1) HPV self-sampling delivered in-person (IP) by a community health worker (CHW; IP + SS) or (2) HPV self-sampling delivered via US mail (SS + Mail). Our primary outcome was HPV self-sampling completion by 6-month post-study enrollment. RESULTS: We enrolled 600 women. Approximately 65% were Hispanic and 35% were Haitian or non-Hispanic Black. Nearly half (43%) had an income of less than $20,000/year and 67% were uninsured. In intent-to-treat analyses, 71.6% of participants in the SS + Mail group and 81.0% of participants in the IP + SS group completed HPV self-sampling. CONCLUSION: Mailed HPV self-sampling is an effective strategy to increase cervical cancer screening among underserved immigrant and ethnic minority women.
Entities:
Keywords:
Cervical cancer screening; HPV; Immigrant; Self-sampling; Women
Authors: Jennifer M Croswell; Douglas A Corley; Jennifer Elston Lafata; Jennifer S Haas; John M Inadomi; Aruna Kamineni; Debra P Ritzwoller; Anil Vachani; Yingye Zheng Journal: Prev Med Date: 2021-06-30 Impact factor: 4.637
Authors: Lisa P Spees; Andrea C Des Marais; Stephanie B Wheeler; Michael G Hudgens; Sarah Doughty; Noel T Brewer; Jennifer S Smith Journal: Trials Date: 2019-12-27 Impact factor: 2.279